N Thibult

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Prognostic Factors in Polyarteritis Nodosa and Churg-Strauss Syndrome A Prospective Study in 342 Patients

François Lhote, M. Gayraud, Pascal Cohen et al. · Medicine · 1996 · 984 citations

Prognostic Factors, Rheumatology, Serum Creatinine +15

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes

Annick Fontbonne, E. Eschw�ge, François Cambien et al. · Diabetologia · 1989 · 620 citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +12

"AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.

Marie‐Germaine Bousser, E Eschwège, M Haguenau et al. · Stroke · 1983 · 611 citations · Full text

Cerebrovascular Disease, Pharmacotherapy, Double Blind +22

Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up

Annick Fontbonne, Marie‐Aline Charles, N Thibult et al. · Diabetologia · 1991 · 385 citations · Full text

Metabolic Syndrome, Healthy Population, Cardiovascular Epidemiology +15